<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        3-584-08
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2008
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        NEOMOX 125MG-5ML SUSPENSION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AMOXICILLIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        25
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Powder for oral suspension
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        5.95
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="NEOPHARMA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            NEOPHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 540]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ZIMMO TRADING ESTABLISHMENT
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            NEOPHARMA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01CA04
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Compoellon (Act .. lngreclent only) :<br />Cllpeu ... : Each capaule contains 250 or 500mg Amoxicillin (as<br />Amoxicillin Trihydrate BP).<br />P-for Orel 5uapenalon: Each 5ml of constituted suspension<br />contain&bull; 125 ar 250mg Amoxlclllln (u Amoxlclllln Tlthydrala BP)<br />Introduction :<br />N8omox i1 &bull; semi-Bynthetic penicillin with a rapid onset of action and<br />broad spectrum of bacte~cldal acGvlly against both Gram-positive and<br />GIIIITHMigll1tva organlomo. It 8Cill by lnhlbhlng tha call wall oynthaolo.<br />NeomDll Ia acid lltable and Ia rapidly and almoat completely<br />abaoJI)ed lrom the gutll)-intestinal tract Almost 90% of the oral<br />doaa iB aboorbed. Pnossnoe of food in the stomach dDeS nol appear<br />to diminish absorption of arnoxlclllln; hence arnoxlclllln can be<br />admlnlstamd with food. Peak plume concantrallon Ia noached at 1 &middot;2<br />houro. Amoxiclllln Ia wldaly dlst~buted a1 varying concentrations In the<br />body tissu&bull; and ftuida with the 8101:8ption of brain and spinal ftuid,<br />BXCIIpl when meningee ...., inflamed. h penelraiBs WBII into mucus,<br />sputum and middle ear ftukl. The han-life of ammclclllln Is 1 to I .5<br />hours. Amoxiclllln lo mainly axcratad In the u~ne unchanged, about<br />80% of oral dosa being excreted In 6 houra.<br />Antlmlcrublal _,rum:<br />NeomDll Is highly actrv. against Gram-positive cocci Including<br />Straptcococl. Pnaumcococl, penicillin -., Staphylococci and<br />Gram-naga11ve organisms Including H. lnftuenae, E. coli, N.<br />gonontloeae, N. meningHidel, P. mirabiliB, Shigella eonnei and<br />Salmonella apeciea.<br />lndl-ona:<br />Upper ReeplretDry Tree! lnl8cllone: Phatyngltla, larynghla, tonelllltla,<br />sinuaitia and otitis media.<br />~ RMplratory Tree! lnr.ctlona: Acute and chronic bronchitia,<br />bronchopneumonia, pneumonia, pulmonaty absoeoaetl and<br />bronchlactaola.<br />CleniiDurlnary Tract lnl8cllone: Cystltla, ureltlrltla, pyelltla,<br />pyelonephrilia, nephritis, p1081atitis, salpingitia, orchitis and<br />gonorrhea.<br />--nall-ona: Enterocolltla, chole&lt;:ystla, pe~tonltla.<br />0-cal end ~loal lnl8cllone: Qoncococal vaglnltla,<br />eeptlc abortion, eeptlc endomelrltla end puerperal fever.<br />Other lnr.tona: Skin and soft tissue infections, ab..,.....,<br />carbunclea and boils.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>NeomDll Ia contralndlcaled In paUenta with &bull;<br />1. a p&quot;&quot;&quot;&quot;&quot;s .._,&#39;Y of hyparaensHMty to penicillins. Attention should<br />be paid to posdlle ~vity with other bBta-lactam<br />antibiotics e.g. Cephalooporlns.<br />2. You haw a viral Infection called lnfacUOUII mononucleosis or glandular<br />fever.<br />3.You have a blood dlleaoe called....., Lymphallc Leukaemia.<br />Spedld ....,lng&bull; a. -Lilian&bull;:<br />Se~ouo and DCOIUIIonally !alai hypa.......nlvlty (anaphylactic) raactlona<br />have bean reported In paUenta on penicillin therapy. Although<br />anaphylaxis is mora frequent following parenteral therapy, it has<br />occurred in patients on oral penicillins. Th111111 reactions are mora<br />llkaly to occur In Individuals with a hl&amp;tory of hyparun&amp;hlvlly to betalactamanUbloUico.<br />Ety!hamatoue raehaa haw bean 888Dclaled wllh glandular fever In<br />patients receiving amoxicillin.<br />Peeudomembranous coiHiB has been reported with nearly all<br />antlllocte~al agents Including amoxlclllln and may n.nge In -.lty<br />from mild to lh-thraatanlng.<br />Prolonged use may occasionally rasult In ovargrowlh of nonsuiiC8ptibla<br />organismo.<br />AI high - ralalive to urinary output, adequala ftuid inmm and<br />urlnaty output must be maintained to mlnlmlle the pDSBiblllty of<br />ammclclllln crystallu~a.<br />Dosage ehould be adjusted In pallants with renal Impairment (Rel8r<br />to Dosage).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Adulla: 250 to 750mg avary 8 hours depending on savarily of<br />lnfBcllon.<br />ChlldNn: 25 &bull; 75mgllcglday In dMdad d01188 avety 8 hou&quot;&#39; depending<br />on eavarlty of Infection.<br />DMage recommandatlona foradulla-lmpelred renal function:<br />Patients with impaired renal function do not generally require<br />a reducdon In dDII8 unlau tha lmpalnnant 11 ........ Pallante with<br />a glomerular ftllraUon rate of 10 to 3tlmVmln ohoukl racalve 500mg<br />or 250mg _.y 12 hou,.., depending upon the MYarlty of Infection.<br />Patients with a r ... 1han 1tlmVmin glomerular filtralicn rate should<br />racaive 500mg or 250mg avery 24 hours, depending upon the ~<br />Dl infection. HemodialySis patients ehould receive 500mg or 250mg<br />&quot;&quot;&quot;&#39;Y 24 houn1, depending on 8BWirity Dl i-. They should<br />racalve an addnlonal dose both du~ng and at the end ol the dialysis.<br />Thoonl I&bull; currwllly no -lng ,_man-n for peedllllrlc<br />petlant8 with Impaired renal function.</p><p>- ot reconelltutlon ( -er for Oral Su.penelon):<br />Shak&amp; the bollia to loosen the powder, add watar up to the mark on<br />the label, invert bollia and shake until all powder iB &lt;lepersed, then<br />slowly add mora watar up to the mark. Keep 1ightly cloeed.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Side-:<br />Amoxicillin ia ganerally wall toleralecl and side effects ara mainly due<br />ID eenahlvlly phenomena.<br />Gastmi..-nal: Nausea, vomiting, &lt;larrhea and hemorrhagic<br />paeduomambranous colitis.<br />Hypelll8noltlvlly raacaono.: Serum slcknaso like raactlon8,<br />etythematoua maculopapular rashea, etythema mullifDnne, SltM!nsJohnson<br />syndrome, B&gt;&lt;loliativa dannatitia, toxic epidermal nactOiysil,<br />acute generalized 8XIIIIIhamatoue pu91uloelo. h)&#39;llBISNIIIIvlly<br />vaecuiHis and urticariiB haw been rBported.<br />uver. A moderate riae in AST (SGon and/or AIL T (SGP&quot;T) has<br />been noted. but the olgnnlcanca ol this lndlng lo unra-n. Hapallc<br />dyafunction including cholostatic jaundice, hepalic choleota&amp;iB and<br />acute cytolytic hepatitis have bean raported.<br />Hemic and Lymphatic: Anemia, Including hemolytic anemia,<br />thrombocytopenia, thrombocytopenic putpura, eoeinophilia,<br />leulcopenia and agranulocytosis have bean reported during therapy<br />with penicillins. Thasa raactlona are ~~~wn~lble on dloconUnuallon<br />of therapy.<br />Central nervous 8)&#39;818m: CNS aida effecto are rare. Tbaea include<br />rava,.bla hyparactlvlty, agitation, anxlaty, lneomnla, conluolon,<br />convulsiDns, behavioural changBB and/or dizzinea&amp;.</p><p>Ovard-:<br />In CllliBB ol DVBrdoaage, diacontinue medication&amp;, lrBBt<br />eymptornetically and institute &quot;&#39;4Jpootiva measuras as required. If 1he<br />ovardosage Is vety racant and there Is no contralndlcallon, an ahampt<br />at emesis or other m&amp;anB of rsmoval of drug from the stomach must be<br />performed. Aanal impainnent appaara to be rawrsible with cassation<br />of drug administration. Ammclclllln may be ramovad from clroolallon<br />by hllmodialy&amp;iB.</p><p>U..ln Pnegn&bull;ncy and ..-.ron:<br />Though ouitability ol amoxicillin in pnognancy has been documented,<br />amoxicillin should be conai- when the potential banefHs outweigh<br />the rlak8 aseoclstad with b&quot;aalmant. Amoxlclllln may be given cll~ng<br />lactaUon.Cautlon should be IIXIIIC!eed when amoxlclllln IB admlnlto<br />nunolng women utraca qu.ntltlaa ara ...areted In braast mllkklk<br />lor your doctofs advice.<br />Druglnt8..ctlona :<br />Amoxiclllln may reduce the eftlcacy of oral contraceptives and hence<br />patients should be warned acconingly.<br />Concurrent admlnlatrallon of allopu~nol du~ng traetman1 with<br />ammclclllln can lncreaee the likelihood of allergic skin reactions.<br />Prolongalion o1 prothrombin time haa bean reported rarely in patients<br />racalvlng amoxlclllln. Therefore, approp~ate monlto~ng ohould be<br />undertaken when antlcosgulanto are pn!IICI&#39;Ibed concurrently.<br />Probenecid decreu&bull; the renal tubular eacration of amoxicillin.<br />Concurrent uee or amoxlolllln and probenecid may result In lnoraeaad<br />and prolonged blood levels of ammclclllln.<br />When lel!lting tor the preaanca of glucoaa in urine with chemical<br />methods, the high u~naty conoantraHon of ammclclllln may lead to<br />falae pooltlve readings. Hence, ~ Is recommended that glucose 1eBta<br />beeed on enzymatic glucose oxidase reactions be ueed.</p><p>P.....,.,lon:<br />capau ... :Pack of 20(10&#39;&amp; bliBtar x 2), 100(10&#39;a blistarx 1 0) and 1000<br />(tO&#39;s blistarx 100) capsulae.<br />P-for Oral s...,....ron: P&quot;&#39;oented as powder in botlles lor<br />preparing 1 oomr.<br />Stability:<br />The preparalion is stable up to the B&gt;q)ity dale appearing on 1he<br />outer pack. The constituted eU8par181on can be kapt for 14 days In<br />tho ralrlgarator.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>: Stora In a dty pi-~ 250C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>NA</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                NA
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Neopharma&nbsp;Abu Dhabi, UAE</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                05/2009
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            NA
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Neomox Powder for Oral Suspension 250 mg/5 ml
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 5 ml of the constituted suspension contains 250 mg of Amoxicillin as Amoxicillin
Trihydrate BP.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder for oral suspension
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Amoxicillin is indicated for the treatment of the following bacterial infections caused by<br />amoxicillin-sensitive gram-positive and gram-negative pathogens (see section 5.1):<br /> Infections of the upper respiratory tract, including infections of the ears, nose and<br />throat: Acute otitis media, acute sinusitis and bacterial pharyngitis.<br /> Infections of the lower respiratory tract: Acute exacerbation of chronic bronchitis,<br />community-acquired pneumonia.<br /> Infections of the lower urinary tract: Cystitis.<br /> Prophylaxis of endocarditis in patients at risk i.e. surgery in the oral cavity or upper<br />airways<br />Consideration should be given to official guidance on the appropriate use of antibacterial<br />agents.<br />Susceptibility of the causative organism to the treatment should be tested (if possible),<br />although may be initiated before the results are available.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The dosage of amoxicillin is dependent on age, bodyweight and renal function of the patient,<br />on the seriousness and localisation of the infection and on the expected or proved causative<br />agent.<br />Standard dosage<br />Adult and adolescents (&gt; 40 kg body weight):<br />The usual dosage covers a range from 750 mg to 3g amoxicillin daily in divided doses. In<br />some areas 1500 mg amoxicillin daily in divided doses are recommended as the upper usual<br />dose.<br />Special dosage recommendation<br />Acute exacerbation of chronic bronchitis in adults: 2 x 1 g per day</p><p>Children&rsquo;s dosage (under 40 kg)<br />The daily dosage for children is 40 - 90 mg/kg/day in two to three divided doses* (not<br />exceeding 3 g/day) depending on the indication, the severity of the disease and the<br />susceptibility of the pathogen (see special dosage recommendations below and sections 4.4,<br />5.1 and 5.2).<br />*PK/PD data indicate that dosing three times daily is associated with enhanced efficacy,<br />thus twice daily dosing is only recommended when the dose is in the upper range.<br />Children weighing more than 40 kg should be given the usual adult dosage.<br />Special dosage recommendation<br />Tonsillitis: 50 mg/kg/day in two divided doses.<br />Acute otitis media: In areas with high prevalence of pneumococci with reduced susceptibility<br />to penicillins, dosage regimens should be guided by national/local recommendations.<br />Dosage for the prevention of endocarditis<br />For the prevention of endocarditis, in patients not having general anaesthetic, 3 g<br />amoxicillin are given orally in the hour preceding the surgical procedure, followed by (6<br />hours later) a further 3 g dose, if considered necessary.<br />For children: 50 mg amoxicillin/kg body weight given as a single dose one hour preceding<br />the surgical procedure.<br />For further details and description of patients at risk local official guidelines for the<br />prevention of endocarditis should be consulted.</p><p>Dosage in patients with impaired renal function:<br />The dose should be reduced in patients with severe renal function impairment.<br />In patients with a renal clearance of less than 30 ml/min an increase in the dosage interval<br />and a reduction in the total daily dose is recommended (see section 4.4 and 5.2).<br />Adults (including older patients):<br />Creatinine clearance<br />ml/min<br />Dose<br />Interval between<br />administration<br />&gt;30 No adjustment necessary -<br />10-30 500 mg 12 h<br />&lt; 10 500 mg 24 h</p><p>In case of hemodialysis: 500 mg should be administered at the end of the procedure.<br />Renal impairment in children under 40 kg:<br />Creatinine clearance<br />ml/min<br />Dose<br />Interval between<br />administration<br />&gt;30 Usual dose No adjustment necessary<br />10-30 Usual dose<br />12 h (corresponding to 2/3<br />of the dose)<br />&lt; 10 Usual dose<br />24 h (corresponding to 1/3<br />of the dose)</p><p>Dosage in patients with impaired hepatic function<br />No dose reduction is necessary as long as the renal function is not impaired.<br />Duration of therapy:<br />In general the therapy should be continued for 2 to 3 days following the disappearance of<br />symptoms. In &beta;-haemolytic streptococcal infections the duration of therapy should be 6-10<br />days in order to achieve eradication of the organism.<br />Method of administration:<br />The preparation is administered orally with a measuring spoon. The measuring spoon is<br />included in the package. The ready-for-use suspension should be taken with a glass of<br />water.<br />The absorption of amoxicillin is not reduced by food intake.<br />Administration to babies: The prescribed dosage is administered undiluted to the baby; milk<br />or tea should be given afterwards.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Amoxicillin is contraindicated in patients with:
• Hypersensitivity to penicillin; a cross-allergy to other beta-lactams such as cephalosporins
should be taken into account.
• Hypersensitivity to the active substance or to any of the excipients listed in section 6.1
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Before initiating therapy with amoxicillin, careful enquiry should be made concerning<br />previous hypersensitivity reactions to penicillins and cephalosporins. The possibility of crosshypersensitivity<br />(10 % - 15 %) with cephalosporins should be taken into account.<br />Serious and occasionally fatal hypersensitivity (anaphylactoid) reactions have been reported<br />in patients on penicillin therapy. These reactions are more likely to occur in individuals with<br />a history of hypersensitivity to beta-lactam antibiotics.<br />In patients with renal function impairment the excretion of amoxicillin will be delayed and,<br />depending on the degree of the impairment, it may be necessary to reduce the total daily<br />dosage (see section 4.2.).<br />The prolonged use of amoxicillin may occasionally result in an overgrowth of nonsusceptible<br />organisms or yeasts. Patients should therefore carefully be watched for super<br />infections.<br />The occurrence of anaphylactic shock and other severe allergic reactions is rare following<br />the oral administration of amoxicillin. However, if such reactions occur, appropriate<br />emergency treatment measures must be taken.<br />The presence of high urinary concentrations of amoxicillin can cause precipitation of the<br />product in urinary catheters. Therefore, catheters should be visually inspected at intervals.<br />At high doses, adequate fluid intake and urinary output must be maintained to minimise the<br />possibility of amoxicillin crystalluria.<br />Amoxicillin should not be used for the treatment of bacterial infections in patients with viral<br />infections, acute lymphatic leukaemia, or infectious mononucleosis as erythematous<br />(morbilliform) rashes have been associated with glandular fever in patients receiving<br />amoxicillin.&nbsp;Antibiotics-associated colitis has been reported with nearly all antibacterial agents and may<br />range in severity from mild to life threatening (see section 4.8). Therefore, it is important to<br />consider this diagnosis in patients who present with diarrhoea during or subsequent to the<br />administration of any antibiotics. Should antibiotic-associated colitis occur, amoxicillin<br />should immediately be discontinued, a physician be consulted and an appropriate therapy<br />initiated. Anti-peristaltic medicinal products are contra-indicated in this situation.<br />As with other beta-lactums, the blood formula should be checked regularly during high-dose<br />therapy.<br />Periodic assessment of organ system functions, including renal, hepatic and haematopoietic<br />functions is advisable during prolonged therapy.<br />High dose therapy with beta-lactums for patients with renal insufficiency or seizures history,<br />treated epilepsy and meningal affection, could be exceptionally lead to seizures.<br />The occurrence of a generalised erythema with fever and pustules at the beginning of<br />treatment should make suspect a generalised acute exanthamatic pustulosis: this<br />necessitates the interruption of therapy and contraindicated any further administration of<br />amoxicillin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Concomitant use not recommended<br />Allopurinol<br />Concomitant administration of allopurinol may promote the occurrence of allergic cutaneous<br />reactions and is therefore not advised.<br />Digoxin<br />An increase in the absorption of digoxin is possible on concurrent administration with<br />amoxicillin. A dose adjustment of digoxin may be necessary.<br />Anticoagulants<br />Concomitant administration of amoxicillin and anticoagulants from the coumarin class, may<br />prolong the bleeding time. A dose adjustment of anticoagulants may be necessary. A large<br />number of cases showing an increase of oral anticoagulant activity have been reported in<br />patients receiving antibiotics. The infectious and inflammatory context, age and the general<br />status of the patient appear as risk factors.&nbsp;In these circumstances, it is difficult to know the part of the responsibility between the<br />infectious disease and its treatment in the occurrence of INR disorders. However, some<br />classes of antibiotics are more involved, notably fluoroquinolones, macrolides, cyclines,<br />cotrimoxazole and some cephalosporins<br />Methotrexate<br />Interaction between amoxicillin and methotrexate leading to methotrexate toxicity has been<br />reported. Serum methotrexate levels should be closely monitored in patients who receive<br />amoxicillin and methotrexate simultaneously. Amoxicillin decreases the renal clearance of<br />methotrexate, probably by competition at the common tubular secretion system.<br />Caution is recommended when amoxicillin is given concomitantly with:<br />Oral hormonal contraceptives<br />Administration of amoxicillin can transiently decrease the plasma level of estrogens and<br />progesterone, and may reduce the efficacy of oral contraceptives. It is therefore<br />recommended to take supplemental nonhormonal contraceptive measures.<br />Other forms of interactions:<br /> Forced diuresis leads to a reduction in blood concentrations by increased elimination<br />of amoxicillin.<br /> It is recommended that when testing for the presence of glucose in urine during<br />amoxicillin treatment, enzymatic glucose oxidase methods should be used. Due to<br />the high urinary concentrations of amoxicillin, false positive readings are common<br />with chemical methods.<br /> Amoxicillin may decrease the amount of urinary estriol in pregnant women.<br /> At high concentrations, amoxicillin may diminish the results of serum glycemia<br />levels.<br /> Amoxicillin may interfere with protein testing when colormetric methods are used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />Amoxicillin passes the placenta and foetal plasma concentrations are approximately 25-30%<br />of the maternal plasma concentrations.&nbsp;Data on a limited number of exposed pregnancies indicate no adverse effects of amoxicillin<br />on pregnancy or on the health of the foetus/new-born child. To date, no other relevant<br />epidemiological data are available. Animal studies do not indicate direct or indirect harmful<br />effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal<br />development. Caution should be exercised when prescribing to pregnant women.<br />Breast-feeding<br />Amoxicillin is excreted into breast milk (approx. 10% of the corresponding serum<br />concentration). So far no detrimental effects for the breast-fed infant have been reported<br />after taking amoxicillin. Amoxicillin can be used during breast-feeding.<br />However, breast-feeding must be stopped if gastrointestinal disorders (diarrhoea, candidosis<br />or skin rash) occur in the new born.<br />4.6 Effects on ability to drive and use machines:<br />No studies on the effects on the ability to drive and use machines have been performed.<br />However, undesirable effects may occur (e.g. allergic reactions, dizziness, convulsions),<br />which may influence the ability to drive and use machines (see section 4.8).</p><p>Very common &ge;1/10<br />Common &ge;1/100 to &lt;1/10<br />Uncommon &ge;1/1,000 to &lt;1/100<br />Rare &ge;1/10,000 to &lt; 1/1,000<br />Very rare &lt;1/10,000</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In this section undesirable effects are defined as follows:<br />Not known (cannot be estimated from the available data)<br />Infections and infestations<br />Uncommon<br />Superinfections and colonization with resistant organisms or yeasts such as oral and vaginal<br />candidiasis after prolonged and repeated use of amoxicillin&nbsp;Blood and the lymphatic system disorders<br />Rare<br />Eosinophilia and haemolytic anaemia.<br />Very rare<br />Leucopenia, neutropenia, granulocytopenia, thrombocytopenia, pancytopenia, anaemia,<br />myelosuppression, agranulocytosis, prolongation of bleeding time, and prolongation of<br />prothrombin time. All were reversible on discontinuation of therapy.</p><p>Immune system disorders<br />Rare<br />Laryngeal oedema, serum sickness, allergic vasculitis, anaphylaxis and anaphylactic shock.<br />Nervous system disorders<br />Rare<br />CNS effects including hyperkinesia, dizziness and convulsions. Convulsions may occur in<br />patients with impaired renal function, epilepsy, meningitis or in those receiving high doses.<br />Gastrointestinal disorders:<br />Common<br />Gastric complaints, nausea, loss of appetite, vomiting, flatulence, soft stools, diarrhoea,<br />enanthemas (particularly in the region of the mouth), dry mouth, taste disturbances. These<br />effects on the gastrointestinal system are mostly mild and frequently disappear either<br />during the treatment or very soon after completion of therapy. The occurrence of these side<br />effects can generally be reduced by taking amoxicillin during meals.<br />Rare<br />Superficial discoloration of the teeth (especially with the suspension). Usually the<br />discoloration can be removed by teeth brushing.<br />Very rare<br />If severe and persistent diarrhoea occurs, the very rare possibility of pseudomembranous<br />colitis should be considered. The a</p><p>Hepato-biliary disorders:<br />Uncommon<br />Moderate and transient increase of liver enzymes.<br />Rare<br />Hepatitis and cholestatic jaundice.<br />Skin and subcutaneous tissue disorders:<br />Common<br />Cutaneous reactions such as exanthema, pruritus, urticaria; the typical morbilliform<br />exanthema occurs 5 - 11 days after start of therapy. Immediate appearance of urticaria<br />indicates an allergic reaction to amoxicillin and therapy should therefore be discontinued.<br />Rare (see also section 4.4).<br />Angioneurotic oedema (Quincke&#39;s oedema), erythema multiforme<br />exsudativum, acute generalized pustulosis, Lyell&rsquo;s syndrome, Stevens-Johnson syndrome,<br />toxic epidermal necrolysis, bullous and exfoliative dermatitis.<br />Renal disorders<br />Rare<br />Acute interstitial nephritis. Crystalluria.<br />General disorders and administration site conditions<br />Rare<br />Drug fever.dministration of antiperistaltic drug is contraindicated.<br />Development of a black tongue.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hepato-biliary disorders:<br />Uncommon<br />Moderate and transient increase of liver enzymes.<br />Rare<br />Hepatitis and cholestatic jaundice.<br />Skin and subcutaneous tissue disorders:<br />Common<br />Cutaneous reactions such as exanthema, pruritus, urticaria; the typical morbilliform<br />exanthema occurs 5 - 11 days after start of therapy. Immediate appearance of urticaria<br />indicates an allergic reaction to amoxicillin and therapy should therefore be discontinued.<br />Rare (see also section 4.4).<br />Angioneurotic oedema (Quincke&#39;s oedema), erythema multiforme<br />exsudativum, acute generalized pustulosis, Lyell&rsquo;s syndrome, Stevens-Johnson syndrome,<br />toxic epidermal necrolysis, bullous and exfoliative dermatitis.<br />Renal disorders<br />Rare<br />Acute interstitial nephritis. Crystalluria.<br />General disorders and administration site conditions<br />Rare<br />Drug fever.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms of overdose:<br />Amoxicillin is not generally associated with acute toxic effects, even when accidentally<br />consumed in high doses. Overdosage can lead to symptoms such as gastrointestinal renal<br />and neuro-psychic disturbances and fluid and electrolyte imbalance. In patients with<br />severely impaired renal function, large overdoses can result in signs of renal toxicity;<br />crystalluria is possible.Management of overdose:<br />There is no specific antidote for an overdose of amoxicillin.<br />Treatment consists primarily of administration of activated charcoal (a gastric lavage is<br />usually not necessary), or symptomatic measures. Particular attention should be paid to the<br />water and electrolyte balance of the patients.<br />Amoxicillin can be eliminated via haemodialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>5. Pharmacological Properties:<br />5.1. Pharmacodynamics:<br />ATC-Code: J01CA04<br />Pharmacotherapeutic group: Beta-lactam antibacterials, Penicillins with extended spectrum.<br />Mode of action<br />Amoxicillin is an aminobenzyl penicillin that has a bactericidal action due to its inhibition of<br />the synthesis of the bacterial cell wall.<br />PK/PD relationship<br />For amoxicillin, time above MIC (T&gt;MIC) is the key pharmacodynamic parameter in<br />predicting a successful clinical and bacteriological outcome.<br />Mechanism of resistance<br />Bacteria may be resistant to amoxicillin due to production of beta-lactamases which<br />hydrolyse aminopenicillins, due to alteration in penicillin-binding proteins, due to<br />impermeability to the drug, or due to drug efflux pumps. One or more of these mechanisms<br />may co-exist in the same organism, leading to a variable and unpredictable cross-resistance<br />to other beta-lactams and to antibacterial drugs of other classes.<br />Breakpoints (EUCAST)</p><p>Organism Susceptibility Breakpoints (&mu;g/ml)<br />Susceptible Intermediate Resistant<br />Haemophilus influenzae &le; 1 -- &gt; 1<br />Moraxella catharrhalis &le; 1 -- &gt; 1<br />Enterococcus &le; 4 8 &gt; 8<br />Streptococcus A, B, C, G1 &le; 0.25 -- &gt; 0.25<br />Streptococcus pneumoniae2 &le; 0.5 1-2 &gt; 2</p><p>- 18 -<br />Organism Susceptibility Breakpoints (&mu;g/ml)<br />Susceptible Intermediate Resistant<br />Enterobacteriaceae,3 -- -- &gt; 8<br />Gram-negative anaerobes &le; 0.5 -- &gt; 2<br />Gram-positive Anaerobes &le; 4 8 &gt; 8<br />Non-species related breakpoints &le; 2 4-8 &gt; 8<br />1 Breakpoint values in the table are based on Benzyl penicillin breakpoints.<br />2 Breakpoint values in the table are based on ampicillin breakpoints.<br />3 The resistant breakpoint of R&gt;8 mg/L ensures that all isolates with resistance<br />mechanisms are reported resistant.</p><p>Susceptibility:<br />The prevalence of resistance may vary geographically and with time for selected species and<br />local information on resistance is desirable, particularly when treating severe infections. As<br />necessary, expert advice should be sought when the local prevalence of resistance is such<br />that the utility of the agent in at least some types of infections is questionable.<br />Commonly susceptible species<br />Aerobic Gram-positive<br />Corynebactierum diphteriae<br />Enterococcus faecalis $<br />Listeria monocytogenes<br />Streptococcus agalactiae<br />Streptococcus bovis<br />Streptococcus pyogenes *<br />Aerobic Gram-negative<br />Helicobacter pylori<br />Anaerobes<br />Peptostreptococci<br />Others<br />Borrelia</p><p>Species for which acquired resistance may be a problem<br />Aerobic Gram-positive<br />Corynebacterium spp<br />Enterococcus faecium $<br />Streptococcus pneumoniae * +<br />Streptococcus viridans<br />Aerobic Gram-negative<br />Escherichia coli +<br />Haemophilus influenzae *<br />Haemophilus para-influenzae *<br />Moraxella catarrhalis +<br />Proteus mirabilis<br />Anaerobes<br />Prevotella<br />Fusobacterium spp<br />Inherently resistant organisms<br />Aerobic Gram-positive<br />Staphylococcus aureus<br />Aerobic Gram-negative<br />Acinetobacter spp<br />Citrobacter spp<br />Enterobacter spp<br />Klebsiella spp<br />Legionella<br />Morganella morganii<br />Proteus vulgaris<br />Providencia spp<br />Pseudomonas spp<br />Serratia spp<br />Anaerobes<br />Bacteroides fragilis</p><p>Others<br />Chlamydia<br />Mycoplasma<br />Rickettsia<br />* Clinical efficacy has been demonstrated for susceptible isolates in approved clinical<br />indications<br />+ pathogens resistance prevalence is &gt; 50%<br />$ Naturally intermediate species</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption:<br />The absolute bioavailability of amoxicillin depends on the dose and ranges between 75 and<br />90%. In the dose range between 250 mg and 1000 mg the bioavailability (parameters: AUC<br />and Cmax) is linearly proportional to the dose. At higher doses the extent of absorption<br />decreases. The absorption is not affected by concomitant food intake. Oral administration of<br />a single dose of 500 mg amoxicillin results in plasma concentrations of 6 - 11 mg/l. After<br />administration of a single dose of 3 g amoxicillin, the plasma concentrations reach 27 mg/l.<br />Peak plasma concentrations are present about 1-2 hours after administration.<br />Distribution:<br />Protein binding for amoxicillin is approximately 17%. Therapeutic drug levels are rapidly<br />achieved in serum, lung tissue, bronchial secretions, middle ear fluid, bile and urine. In<br />healthy meninges amoxicillin diffuses badly in liquor cerebrospinalis. Amoxicillin crosses the<br />placenta and a small percentage is excreted into the breast milk.<br />Biotransformation and elimination:<br />The main route of excretion of amoxicillin is the kidney. About 60-80% of an oral dose of<br />amoxicillin is excreted in unchanged active form in the urine within 6 hours of<br />administration, and a small fraction is excreted in the bile. Approximately 7 - 25% of the<br />administered dose is metabolised to inactive penicilloic acid. The serum half-life in patients<br />with normal renal function is approximately 1 &ndash; 1,5 hour. In patients with end-stage renal<br />failure the half-life ranges between 5 to 20 hours. The substance is haemodialysable.&nbsp;<strong>Pediatric population<br />In preterm infants with gestational age 26-33 weeks, the total body clearance after<br />intravenous dosing of amoxicillin, day 3 of life, ranged between 0.75 &ndash; 2 ml/min, very<br />similar to the inulin clearance (GFR) in this population.<br />Following oral administration, the absorption pattern and the bioavailability of amoxicillin in<br />small children may be different to that of adults. Consequently, due to the decreased CL,<br />the exposure is expected to be elevated in this group of patients, although this increase in<br />exposure may in part be diminished by decreased bioavailability when given orally.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical data reveal no special hazard for humans based on conventional studies of safety<br />pharmacology, repeated dose toxicity, genotoxicity and toxicity to reproduction.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>S. No. Ingredient mg/5 ml Function<br />EXCIPIENTS<br />1. Sucrose BP 2073.11 Sweetening agent<br />2. Sodium Benzoate BP 5.00 Preservative<br />3. Carmellose Sodium BP 36.25 Thickening agent<br />4. Sodium Citrate BP 15.00 Buffering agent<br />5. Citric Acid BP 0.50 Buffering agent<br />6. Carmoisine 0.75 Colour<br />7. Colloidal Anhydrous Silica BP 13.75 Glidant<br />8. Tutti Frutti Flavor 40.00 Flavour</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Before constitution keep in a dry place below 25C<br />Once constituted, the suspension must be stored in a refrigerator and used within 14 days.<br />Do not freeze.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pack Size: 100 ml<br />Amber glass bottle sealed with child resistant cap.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Neopharma, Abu Dhabi, UAE
Plot No. A1 89-95,
Industrial City of Abu Dhabi (ICAD),
Mussafah, Abu Dhabi, UAE
8. Marketing Authorization Holder:
Neopharma, Abu Dhabi, UAE
Plot No. A1 89-95,
Industrial City of Abu Dhabi (ICAD),
Mussafah, Abu Dhabi, UAE
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                NA
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>